These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26861665)

  • 1. Robust method for TALEN-edited correction of pF508del in patient-specific induced pluripotent stem cells.
    Camarasa MV; Gálvez VM
    Stem Cell Res Ther; 2016 Feb; 7():26. PubMed ID: 26861665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells.
    Crane AM; Kramer P; Bui JH; Chung WJ; Li XS; Gonzalez-Garay ML; Hawkins F; Liao W; Mora D; Choi S; Wang J; Sun HC; Paschon DE; Guschin DY; Gregory PD; Kotton DN; Holmes MC; Sorscher EJ; Davis BR
    Stem Cell Reports; 2015 Apr; 4(4):569-77. PubMed ID: 25772471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.
    Ramalingam S; Annaluru N; Kandavelou K; Chandrasegaran S
    Curr Gene Ther; 2014; 14(6):461-72. PubMed ID: 25245091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs.
    Sun N; Zhao H
    Biotechnol Bioeng; 2014 May; 111(5):1048-53. PubMed ID: 23928856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
    Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
    Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent labeling and visualization of human induced pluripotent stem cells with the use of transcription activator-like effector nucleases.
    Sekine K; Takebe T; Taniguchi H
    Transplant Proc; 2014 May; 46(4):1205-7. PubMed ID: 24815161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo delivery.
    Cooney AL; Singh BK; Sinn PL
    Mol Ther; 2015 Apr; 23(4):667-74. PubMed ID: 25557623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclease-mediated double-strand break (DSB) enhancement of small fragment homologous recombination (SFHR) gene modification in human-induced pluripotent stem cells (hiPSCs).
    Sargent RG; Suzuki S; Gruenert DC
    Methods Mol Biol; 2014; 1114():279-90. PubMed ID: 24557910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells with CytoTune, a non-integrating Sendai virus.
    Lieu PT; Fontes A; Vemuri MC; Macarthur CC
    Methods Mol Biol; 2013; 997():45-56. PubMed ID: 23546747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seamless Gene Correction in the Human Cystic Fibrosis Transmembrane Conductance Regulator Locus by Vector Replacement and Vector Insertion Events.
    Suzuki S; Chosa K; Barillà C; Yao M; Zuffardi O; Kai H; Shuto T; Suico MA; Kan YW; Sargent RG; Gruenert DC
    Front Genome Ed; 2022; 4():843885. PubMed ID: 35465025
    [No Abstract]   [Full Text] [Related]  

  • 11. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing.
    Hotta A; Yamanaka S
    Annu Rev Genet; 2015; 49():47-70. PubMed ID: 26407033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis.
    Villate-Beitia I; Zarate J; Puras G; Pedraz JL
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1071-1081. PubMed ID: 28270008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome engineering in human cells.
    Song M; Kim YH; Kim JS; Kim H
    Methods Enzymol; 2014; 546():93-118. PubMed ID: 25398337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient genome engineering by targeted homologous recombination in mouse embryos using transcription activator-like effector nucleases.
    Sommer D; Peters A; Wirtz T; Mai M; Ackermann J; Thabet Y; Schmidt J; Weighardt H; Wunderlich FT; Degen J; Schultze JL; Beyer M
    Nat Commun; 2014; 5():3045. PubMed ID: 24413636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs.
    Wu Y; Hu Z; Li Z; Pang J; Feng M; Hu X; Wang X; Lin-Peng S; Liu B; Chen F; Wu L; Liang D
    Sci Rep; 2016 Jan; 6():18865. PubMed ID: 26743572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Gene Editing in Pluripotent Stem Cells by Bacterial Injection of Transcription Activator-Like Effector Nuclease Proteins.
    Jia J; Bai F; Jin Y; Santostefano KE; Ha UH; Wu D; Wu W; Terada N; Jin S
    Stem Cells Transl Med; 2015 Aug; 4(8):913-26. PubMed ID: 26062981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
    Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
    Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.
    Suzuki K; Yu C; Qu J; Li M; Yao X; Yuan T; Goebl A; Tang S; Ren R; Aizawa E; Zhang F; Xu X; Soligalla RD; Chen F; Kim J; Kim NY; Liao HK; Benner C; Esteban CR; Jin Y; Liu GH; Li Y; Izpisua Belmonte JC
    Cell Stem Cell; 2014 Jul; 15(1):31-6. PubMed ID: 24996168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome editing in human stem cells.
    Byrne SM; Mali P; Church GM
    Methods Enzymol; 2014; 546():119-38. PubMed ID: 25398338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.